Search
Showing results for "1"
We believe the way we reward research excellence is better than anywhere in the nation. Find out about the ways The Kids Research Institute Australia rewards our researchers.
Research
National Hybrid Closed-Loop Outpatient TrialThe national Hybrid Closed-Loop Outpatient Trial will test the use of an automated insulin delivery system to see if it is better at optimising blood glucose levels than standard therapy.
Research
Distress and psychological morbidity do not reduce over time in carers of patients with high-grade gliomahis study aimed to determine how carer distress and psychological morbidity change over time following a patient's diagnosis of high-grade glioma
News & Events
New study: Managing T1D During Exercise in High-Level AthletesThe aim of this study is to describe the strategies used by competitive athletes with T1D to successfully manage their condition during sport and exercise.
News & Events
New study: Mobile Food Record in T1DWe are looking for people aged between 9 and 18 years with type 1 diabetes to participate in a mobile food study. You will be asked to take images of what you eat over a consecutive four-day period using the Mobile Food Record App. There will be no dietary restrictions in place during this period.
News & Events
What is DACS?DACS – Diabetes Ambulatory Care Service – is a new model of care at Perth Children’s Hospital for children newly diagnosed with type 1 diabetes.
Research
Randomised controlled trial analysing supplementation with 250 versus 500 units of vitamin D3, sun exposure and surrounding factors in breastfed infantsThe rate of non-compliance with vitamin D supplementation is as high as 45%. This is why randomised controlled trials are needed to analyse the response...
Research
How do high protein and/or high fat meals affect postprandial glycaemic control in children using intensive insulin therapy?Investigating the effect of fat and protein content of a standardised carbohydrate meal on the post-prandial glycaemic response in children with type 1 diabetes
Research
Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndromeIn 2014, germline signal transducer and activator of transcription (STAT) 3 gain-of-function (GOF) mutations were first described to cause a novel multisystem disease of early-onset lymphoproliferation and autoimmunity.
Research
Declining transition rates to psychotic disorder in "ultra-high risk" clients: Investigation of a dilution effectLater ultra-high risk psychosis cohorts presented with different clinical intake characteristics than earlier cohorts